Company profile
Atrin Pharmaceuticals company profile
Atrin Pharmaceuticals is a privately held biopharmaceutical company, based in Doylestown, PA, that aims to change the way cancer is being treated. The company is engaged in the discovery and development of innovative treatments for cancer. The company's most advanced program is focused on a new class of compounds that are highly specific inhibitors of ATR, a key mediator of DNA repair. Atrin is further assembling a pipeline of additional drug candidates, identified via the company's proprietary, human cell-based, high-throughput screening platform, Atrize™. Applicable to both drug discovery/development and the evaluation of patient-specific treatments, Atrize enables the rapid identification and evaluation of compounds that are effective in inhibiting cancer cell viability without adversely affecting healthy cells.
Business identity
- Website
- http://www.atrinpharma.com/
- Contact email
- [email protected]
- Phone number
- (215) 589-6356
- Operating status
- Active
- Company type
- For Profit
- Employee range
- 1-10 employees
- Revenue range
- $0+
- Founded
- 2011-01-01, Year
Headquarters
- Headquarters
- Potsdam, New York, United States
- Postal code
- 18902
- Country code
- US
- Continent
- North America